Related Experiment Video

Updated: Aug 6, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer

Anshu Agrawal1, Jianhui Yang, Richard F Murphy

  • 1Department of Biomedical Sciences, Medicine, and Medical Microbiology and Immunology, Creighton University School of Medicine, CRISS II Room 510, 2500 California Plaza, Omaha, NE 68178, USA.

Experimental and Molecular Pathology
|August 22, 2006
PubMed

Insights

Understanding the p14ARF-Mdm2-p53 pathway in breast cancer is crucial. This review details how factors like Pokemon and Geminin influence this pathway, impacting cancer development and therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer pathogenesis involves mutations in tumor suppressor genes like p14ARF and p53.
  • The Mdm2 protein acts as a key mediator for both p14ARF and p53 functions.
  • Understanding protein interactions within this pathway is vital for comprehending cancer development.

Purpose of the Study:

  • To review the roles of proteins influencing the p14ARF-Mdm2-p53 pathway in breast cancer.
  • To discuss the impact of mutations in p53 on pathway function.
  • To highlight the complexity of this pathway and its implications for cancer.

Main Methods:

  • Literature review of studies on the p14ARF-Mdm2-p53 pathway.
  • Analysis of factors affecting protein interactions within the pathway.
  • Discussion of consequences of p53 mutations.

Main Results:

  • Pokemon, Geminin, Twist, and Apigenin are identified as key regulators of the p14ARF-Mdm2-p53 pathway.
  • The intricate interactions within the pathway contribute to breast cancer development.
  • Specific p53 mutations significantly alter pathway dynamics.

Conclusions:

  • The p14ARF-Mdm2-p53 pathway is a complex network critical to breast cancer.
  • Targeting components of this pathway offers potential for novel therapeutic interventions.
  • Further research into pathway interactions may yield innovative cancer treatments.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...